Medicinal products: products of chemical or biological origin which are intended to have or are presented as having a medicinal effect on the human or animal organism, in particular in the diagnosis, prevention or treatment of diseases, injuries and handicaps; blood and blood products are also considered to be medicinal products (relevant tariff items: 3002, 3003, 3004)

Draft revision of the Ordinance on Licensing in the Medicinal Products Sector, 41 pages, available in German, French and Italian.

The Ordinance on Licensing in the Medicinal Products Sector (SR 812.212.1) is being currently revised due to numerous amendments relating to the ordinary revision of the Therapeutic Products Act (TPA) adopted by Parliament on 18 March 2016 as well as to the approval and implementation of the Medicrime Convention adopted by Parliament on 29 September 2017.

The following amendments of the above mentioned ordinance may be relevant for international trade:

•  more detailed specifications with regard to the licence for the import, export and foreign trade of medicinal products

•  new licence for the activities of brokers

•  simplifications with regard to the individual import of immunological medicinal products or blood/blood products

•  new regulation concerning the import of unauthorised medicinal products in small quantities by private individuals and by health professionals